Stem-cell transplants show limited benefit for double-hit lymphoma patients in remission – Science Daily
|
Stem–cell transplants show limited benefit for double-hit lymphoma patients in remission
Science Daily Patients with double hit lymphoma (DHL) who undergo autologous stem–cell transplantation (autoSCT) after achieving remission are not more likely to remain in remission or live longer than patients who do not undergo autoSCT, according to a new analysis … |
